The JSE was weaker on Thursday, along with its global counterparts, as Covid-19 vaccine hopes were dampened by concerns over US-China tension and rising infection numbers.

The dispute between the US and China over control of advanced technologies continues to weigh on investor risk appetite, while  a resurgence of Covid-19 in some economies is triggering implementation of restrictions on business activity that may threaten economic growth.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now